A study of different markers for neuroendocrine differentiation in breast carcinomas
- PMID: 2431399
- DOI: 10.1016/S0344-0338(86)80144-3
A study of different markers for neuroendocrine differentiation in breast carcinomas
Abstract
Forty-two breast carcinomas were studied with different markers for detecting neuroendocrine differentiation. The Bodian and Grimelius silver stains were applied, as well as immunostaining for neurone specific enolase (NSE), chromogranin, prealbumin and a battery of hormones. All cases were studied by electron microscopy as well. The material included 29 infiltrating ductal carcinomas, 10 infiltrating lobular carcinomas and 3 tubular carcinomas. Immunostaining for hormones was obtained in 11 cases (gastrin and PP (4 cases each), leu-enkephalin (3 cases), substance P (2 cases), beta-endorphin (2 cases), ACTH (1 case) and bombesin (1 case). Three cases revealed immunostaining for more than one hormone. Sixteen cases were positively stained with rabbit anti-NSE (Dako Corporation) and included all the 11 cases with proven immunoreactivity for hormones. 20 cases were positively stained with sheep anti-NSE and only 8 of the 11 cases with immunoreactivity for hormones were included. Immunostaining for prealbumin was observed in only 1 case and chromogranin in only 5 cases. All cases were unstained with the Bodian stain, whereas 3 cases showed a positive argyrophilic reaction with the Grimelius technique. Ultrastructural studies revealed typical small membrane-bound electron dense granules in cytoplasm in 4 cases, all among the 11 cases with immunoreactivity for hormones. We conclude that immunostaining with rabbit anti-NSE is the best screening method for detecting breast carcinomas with neuroendocrine differentiation.
Similar articles
-
Neurone specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations.J Pathol. 1986 Jan;148(1):35-43. doi: 10.1002/path.1711480107. J Pathol. 1986. PMID: 3003312
-
C-erbB-2 protein and neuroendocrine expression in breast carcinomas.Anticancer Res. 1991 Jan-Feb;11(1):161-7. Anticancer Res. 1991. PMID: 1673329
-
Immunocytochemical evidence for neuroendocrine differentiation in human breast carcinomas.J Pathol. 1985 Dec;147(4):281-9. doi: 10.1002/path.1711470406. J Pathol. 1985. PMID: 3003310
-
Neuroendocrine differentiation in breast lesions.Pathol Res Pract. 1988 Apr;183(2):214-21. doi: 10.1016/S0344-0338(88)80048-7. Pathol Res Pract. 1988. PMID: 3290869 Review.
-
Neuroendocrine primary small cell carcinoma of the breast. Report of a case and review of the literature.Am J Clin Oncol. 1995 Apr;18(2):133-8. doi: 10.1097/00000421-199504000-00008. Am J Clin Oncol. 1995. PMID: 7534975 Review.
Cited by
-
The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.J Endocrinol Invest. 1994 Mar;17(3):207-25. doi: 10.1007/BF03347721. J Endocrinol Invest. 1994. PMID: 8051343 Review. No abstract available.
-
Chromogranin A immunoreactivity and Grimelius' argyrophilia. A correlative study in mammalian endocrine cells.Anat Embryol (Berl). 1992;185(3):207-15. doi: 10.1007/BF00211819. Anat Embryol (Berl). 1992. PMID: 1349463
-
Primary oat cell (neuroendocrine) carcinoma of the breast. Report of four cases.Virchows Arch A Pathol Anat Histopathol. 1992;420(1):103-8. doi: 10.1007/BF01605991. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1311484
-
Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot, and hybridization analyses.Am J Pathol. 1990 Feb;136(2):319-27. Am J Pathol. 1990. PMID: 2305832 Free PMC article.
-
Carcinomas of the breast with endocrine differentiation: a review.Virchows Arch. 1994;425(5):449-57. doi: 10.1007/BF00197547. Virchows Arch. 1994. PMID: 7850068 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous